Health Care: Drugs

Forest Laboratories Inc (FRX: )

$99 -0.77 | -0.77%
06/30/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 2.84
52 Week High 7.50
52 Week Low 2.01
Avg. Daily Vol. (Mil) 0.00
Beta (3 year) -1.03
Share Related Items
Mkt Cap (Mil) 30.16
Shares Out (Mil) 10.62
Float (Mil) 5.20
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 1.30
Current Ratio 1.30
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.00
Price/Book 42.38
Price/Cash Flow -11.90
Per Share Data
Earnings -0.26
Sales 0.00
Book Value 0.07
Cash Flow -0.24
Business Summary
Fennec Pharmaceuticals Inc is a biotechnology company developing Sodium Thiosulfate, a chemo-protectant against hearing loss associated with platinum-basedanti-cancer agents in children.
General Information
68 TW Alexander Drive
PO Box 13628
Research Triangle, NC 27709
www.fennecpharma.com
Industry : Drugs
Sector: Health Care
Employees: 1
CEO: Mr. Rostislav Raykov
Short Interest
Current Month (Mil) 0.00
Previous Month (Mil) 0.00
Short Interest Ratio (Days) 0.10
Management Effectiveness
Return on Equity n.a.
Return on Assets -91.70
Return on Investments -355.00
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with FRX

Latest FRX Headlines from TheStreet

More Financial News for FRX

Press Releases for FRX

See All Press Releases

Partner Headlines for FRX

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter